Source comparison
Melanotan-2 Fair Skin Starting Dose Guide: Reconstitution and Storage Protocol Comparison
Reconstitution ratio 1mg MT-2 per 1mL bacteriostatic water (1mg/mL) 2mg per 1mL (2mg/mL concentration) 1mg/mL allows precise 0.1mg dose adjustments using insulin syringes marked in 0.01mL increments. Critical for fair-skin titration where 0.1mg changes matter
This comparison does not assign a generated winner or score.
- Reconstitution ratio
- 1mg MT-2 per 1mL bacteriostatic water (1mg/mL)
- 2mg per 1mL (2mg/mL concentration)
- 1mg/mL allows precise 0.1mg dose adjustments using insulin syringes marked in 0.01mL increments. Critical for fair-skin titration where 0.1mg changes matter
- Storage temperature
- 2–8°C refrigerated immediately after reconstitution
- Room temperature or inconsistent refrigeration
- MT-2 degrades at temperatures above 8°C. Every hour above this threshold causes irreversible peptide bond cleavage that neither appearance nor colour change reveals
- Injection timing
- Evening administration (6–8pm)
- Morning or random timing
- Nausea peaks 60–90 minutes post-injection; evening dosing allows users to sleep through the worst of it, improving protocol adherence
- Syringe gauge
- 29G or 31G insulin syringe, 0.5mL or 1mL capacity
- 27G or larger, non-insulin syringes
- Insulin syringes have dead space <0.01mL, ensuring dose accuracy within ±0.02mg. Essential when working in the 0.25–0.5mg range where ±10% variance changes outcomes
- UV exposure timing
- Begin controlled UV exposure (10–15 minutes) starting Day 5–7 of protocol
- Immediate UV exposure or delayed until Day 14+
- MT-2 primes melanocytes but requires UV stimulus to complete eumelanin polymerisation. Starting UV too early risks burn before melanin deposition; too late wastes the loading phase